ArticleScientific reports2026
Modeling and application of alzheimer's disease complex trait prediction based on multi-task learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Alzheimer’s disease (AD) is a complex disorder influenced by genetic factors, and related phenotypes often share common genetic mechanisms. However, traditional genetic risk prediction models typically focus on a single phenotype, neglecting valuable cross-phenotype information. This study aims to explore the effectiveness of multi-task learning (MTL) in modeling genetic data for AD and to assess whether aggregating genetic signals at the gene level can further improve prediction accuracy. We applied two representative MTL models, including the Sluice Network and the Learning to Branch (LTB) model, and compared them with single-task learning (STL) and hard parameter sharing (HPS) models. Simulation experiments were conducted to evaluate model performance under different conditions, followed by validation using genetic and phenotypic data from the ADNI cohort. Results show that the Sluice Network outperformed all other models under various sharing conditions, benefiting from its flexible parameter-sharing mechanism. LTB and HPS performed well under high sharing but showed significant degradation when sharing was low. Furthermore, gene-level genetic variants aggregation further improved prediction performance, particularly in the Sluice Network and LTB models. These findings suggest that MTL combined with biologically-informed feature aggregation holds promise for genetic risk prediction in AD and other complex diseases. By utilizing cross-phenotype genetic information and aggregating signals at the gene level, MTL offers a more comprehensive and accurate approach to genetic risk prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.